Completed PHASE1 NCT05862701
Comparison of Topical 5% Permethrin and Topical 10% Sulfur in the Treatment of Scabies
Sponsor: Combined Military Hospital Abbottabad
Conditions
Scabies
Interventions
Permethrin Sulphur
Updated 3 times since 2023 Last updated: May 8, 2023 Started: Mar 1, 2022 Primary completion: Sep 30, 2022 Completion: Sep 30, 2022
Listed as NCT05862701, this PHASE1 trial focuses on Scabies and remains completed. Sponsored by Combined Military Hospital Abbottabad, it has been updated 3 times since 2022, reflecting limited change activity. This study adds to the evidence base for this therapeutic area through structured, versioned documentation.
Change History
3 versions recorded-
Sep 2024 — Present [monthly]
Completed PHASE1
-
Jul 2024 — Sep 2024 [monthly]
Completed PHASE1
-
Jun 2023 — Jul 2024 [monthly]
Completed PHASE1
First recorded
Mar 2022
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Combined Military Hospital Abbottabad
Data source: Combined Military Hospital Abbottabad
For direct contact, visit the study record on ClinicalTrials.gov .
Study Locations
- • Abbottābād, Pakistan